• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TIPS in Patients With Refractory Ascites: Review of Literature and Current Recommendations.

作者信息

Abad-Santos Matthew, Jeffries James, Hua Charles, Johnson Guy E

机构信息

Department of Radiology, Section of Interventional Radiology, University of Washington, Seattle, WA.

Department of Radiology, Section of Interventional Radiology, University of Washington, Seattle, WA.

出版信息

Tech Vasc Interv Radiol. 2025 Sep;28(3):101057. doi: 10.1016/j.tvir.2025.101057. Epub 2025 Jul 6.

DOI:10.1016/j.tvir.2025.101057
PMID:40784685
Abstract

In cirrhotic patients, refractory ascites (RA) is a devastating consequence of portal hypertension and is associated with high morbidity and mortality. Over the past quarter century, transjugular intrahepatic portosystemic shunt (TIPS) placement has become a key treatment for patients with RA, but there has been an evolution of patient evaluation, stents, and procedural techniques during this time. As such, the rates of ascites control, survival, and associated hepatic encephalopathy have evolved as well. This review examines the evidence and current recommendations for TIPS in the setting of RA.

摘要

相似文献

1
TIPS in Patients With Refractory Ascites: Review of Literature and Current Recommendations.
Tech Vasc Interv Radiol. 2025 Sep;28(3):101057. doi: 10.1016/j.tvir.2025.101057. Epub 2025 Jul 6.
2
Predicting Morbidity and Mortality After Transjugular Intrahepatic Portosystemic Shunt Placement: A Review of Existing Models and Future Directions.经颈静脉肝内门体分流术(TIPS)置入术后发病率和死亡率的预测:现有模型综述与未来方向
Tech Vasc Interv Radiol. 2025 Sep;28(3):101062. doi: 10.1016/j.tvir.2025.101062. Epub 2025 Jul 14.
3
The transjugular intrahepatic portosystemic shunt for the management of cirrhotic refractory ascites.经颈静脉肝内门体分流术治疗肝硬化难治性腹水
Nat Clin Pract Gastroenterol Hepatol. 2006 Jul;3(7):380-9. doi: 10.1038/ncpgasthep0523.
4
Intrahepatic Portosystemic Shunt (TIPS): Evolving Indications.肝内门体分流术(TIPS):不断演变的适应证
Tech Vasc Interv Radiol. 2025 Sep;28(3):101055. doi: 10.1016/j.tvir.2025.101055. Epub 2025 Jul 15.
5
Sarcopenia is a risk factor for post-transjugular intrahepatic portosystemic shunt hepatic encephalopathy and mortality: A systematic review and meta-analysis.肌肉减少症是经颈静脉肝内门体分流术肝性脑病和死亡率的一个风险因素:系统评价和荟萃分析。
Indian J Gastroenterol. 2024 Aug;43(4):748-759. doi: 10.1007/s12664-023-01465-2. Epub 2023 Dec 12.
6
Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis.肝硬化患者经颈静脉肝内门体分流术置入后的发病率和死亡率。
Eur J Gastroenterol Hepatol. 2019 May;31(5):626-632. doi: 10.1097/MEG.0000000000001342.
7
Cardiovascular risk assessment and predictors of cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with cirrhosis.肝硬化患者经颈静脉肝内门体分流术后的心血管风险评估及心脏失代偿的预测因素
World J Gastroenterol. 2025 Jul 21;31(27):107740. doi: 10.3748/wjg.v31.i27.107740.
8
Recurrent Portal Hypertension after Liver Transplant: Impact on Survival and the Role of Transjugular Intrahepatic Portosystemic Shunt Creation in Management.
J Vasc Interv Radiol. 2025 May;36(5):768-775. doi: 10.1016/j.jvir.2025.01.027. Epub 2025 Jan 21.
9
Expanded polytetrafluoroethylene (ePTFE)-covered stents versus bare stents for transjugular intrahepatic portosystemic shunt in people with liver cirrhosis.聚四氟乙烯覆膜支架与裸支架经颈静脉肝内门体分流术治疗肝硬化的效果比较。
Cochrane Database Syst Rev. 2023 Aug 2;8(8):CD012358. doi: 10.1002/14651858.CD012358.pub2.
10
The Impact of Transjugular Intrahepatic Portosystemic Shunt on Nutrition in Liver Cirrhosis Patients: A Systematic Review.经颈静脉肝内门体分流术对肝硬化患者营养状况的影响:系统评价。
Nutrients. 2023 Mar 27;15(7):1617. doi: 10.3390/nu15071617.